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The anosmin-1 protein family regulates cell migration, axon guidance, and branching, by mechanisms that are not well understood. We show
that the C. elegans anosmin-1 ortholog KAL-1 promotes migrations of ventral neuroblasts prior to epidermal enclosure. KAL-1 does not modulate
FGF signaling in neuroblast migration and acts in parallel to other neuroblast migration pathways. Defects in heparan sulfate (HS) synthesis or in
specific HS modifications disrupt neuroblast migrations and affect the KAL-1 pathway. KAL-1 binds the cell surface HS proteoglycans syndecan/
SDN-1 and glypican/GPN-1. This interaction is mediated via HS side chains and requires specific HS modifications. SDN-1 and GPN-1 are
expressed in ventral neuroblasts and have redundant roles in KAL-1-dependent neuroblast migrations. Our findings suggest that KAL-1 interacts
with multiple HSPGs to promote cell migration.
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Anosmins are a family of conserved secreted proteins that
regulate cell migration and axon branching. Anosmin was first
identified as being defective in human Kallmann syndrome
(KS), a genetic disease combining anosmia and hypogonadism.
The gonadal defects in KS patients result from lack of pituitary
gonadotrophic hormones (hypogonadotrophic hypogonadism)
(Gonzalez-Martinez et al., 2004a; MacColl et al., 2002; Rugarli,
1999). During development, olfactory sensory neurons extend
axons in the lateral olfactory tract (LOT) towards the rostral
telencephalon and then, after a delay, defasciculate and send
collateral branches into the developing olfactory bulb (OB)
(Key and St John, 2002). In KS patients, the final phase of
branching into the OB is thought to be defective (Schwanzel-
Fukuda et al., 1989).
Kallmann syndrome is genetically heterogeneous, with X-
linked recessive, autosomal dominant, and autosomal recessive
forms known. Recessive X-linked KS is caused by mutations⁎ Corresponding author.
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1993; Legouis et al., 1991), which encodes a secreted protein,
anosmin-1. Anosmin-1 defines a conserved family of proteins
that contain a whey acidic protein-like motif (the WAP
domain) found in serine protease inhibitors, and four
fibronectin type III (FNIII) repeats. Anosmin-1 is secreted by
neurons of the OB and localizes to the extracellular matrix of
the OB (Hardelin et al., 1999), suggesting it acts as a short-
range signal for LOT axons that induces their branching as
they pause at the surface of the telencephalon. In explant
assays, anosmin-1 stimulates branching of both LOT and OB
neurons (Soussi-Yanicostas et al., 2002).
How does anosmin-1 affect axon outgrowth, branching, and
cell migration? Several lines of evidence suggest that anosmin-1
function may involve heparan sulfate proteoglycans (HSPGs).
Anosmin-1 binding to membrane fractions of neurons can be
competed with heparin, and anosmin-1 binds heparan sulfate
(HS) with nanomolar affinity (Hu et al., 2004; Soussi-
Yanicostas et al., 1996, 1998). However, specific HSPGs
involved in anosmin-1 functions have not yet been identified.
Furthermore, it has not yet been resolved whether HSPGs are
the cellular receptors for anosmin-1, whether they mediate an
Table 1
kal-1 synergizes with null mutations in components of known VNB migration
pathways
Genotype Embryonic
lethality
(%) ±SEM
Larval lethality
(%) ±SEM
Adult Vab
morphology
(%) ±SEM
Wild type 0.1 ± 0.1 0.1 ± 0.1 0.1 ± 0.2
kal-1(gb503) 0.6 ± 0.6 0.2 ± 0.2 5.6 ± 0.7
vab-1(e2027) 44.4 ± 2.8 22.8 ± 3.2 31.0 ± 3.0
kal-1 vab-1 54.6 ± 2.5* 32.6 ± 1.8* 12.4 ± 1.4
efn-1(e96) 22.4 ± 2.9 14.1 ± 1.9 50.3 ± 1.3
kal-1 efn-1 27.7 ± 7.7 37.2 ± 1.8*** 29.3 ± 2.9
efn-4(bx80) 11.5 ± 1.1 9.0 ± 1.8 31.2 ± 1.7
kal-1 efn-4 35.3 ± 4.2*** 24.1 ± 2.5*** 26.2 ± 1.4
mab-20(ev574) 19.8 ± 2.1 32.7 ± 1.3 27.7 ± 1.2
kal-1 mab-20 27.0 ± 0.2** 29.5 ± 2.9 34.7 ± 1.3***
ptp-3(mu256) 5.5 ± 1.4 1.1 ± 0.5 4.5 ± 0.4
kal-1 ptp-3 8.7 ± 0.8 4.4 ± 1.2** 11.4 ± 1.4***
sax-3(ky123) 46.4 ± 4.3 31.8 ± 2.4 16.1 ± 2.4
kal-1 sax-3 57.9 ± 3.9 ns 37.0 ± 2.8 ns 4.3 ± 1.3
The penetrance of at least one morphogenetic phenotype (embryonic lethality,
larval lethality or aberrant epidermal morphology in adults) was enhanced in a
kal-1(gb503) background relative to the single mutant alone. The enhancement
of total (embryonic plus larval) lethality in sax-3 kal-1 is highly significant
relative to sax-3 alone, although the individual measures are not significantly
different. In some double mutant combinations (e.g., kal-1 vab-1, kal-1 sax-3)
the fraction of animals with adult Vab phenotypes is lower than the control
because an increased fraction of the population died earlier in development. All
mutations used are null, by genetic or molecular criteria (see Materials and
methods). Genotypes were compared by Student's t test; *P < 0.05, **P < 0.01,
***P < 0.005; all comparisons are between the matched kal-1(+) and kal-1(−)
strains.
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whether HSPGs solely act to localize or anchor anosmin-1.
The genetic basis of autosomal dominant KS has recently
been traced to FGFR1, encoding a fibroblast growth factor
receptor (Dode et al., 2003). The involvement of FGFR1 and
anosmin-1 in the same syndrome suggests that anosmin-1 might
affect FGFR signaling (Dode and Hardelin, 2004). Anosmin-1
can stimulate FGFR1 signaling in human neuroblasts (Gonza-
lez-Martinez et al., 2004b). Tissue-specific deletion of Fgfr1 in
the telencephalon causes defects in OB morphogenesis (Hebert
et al., 2003), reminiscent of KS. However, unlike KS, olfactory
axons enter the OB in the mouse Fgfr1 mutants, suggesting that
the mechanisms of autosomal dominant and X-linked recessive
KS may differ.
Invertebrate anosmin-1 orthologs have been found in C.
elegans (Rugarli et al., 2002) and in Drosophila (Andrenacci et
al., 2004). The C. elegans gene kal-1 has been shown to affect
epidermal morphogenesis, development of male tail sensilla,
and axon branching (Rugarli et al., 2002). Overexpression of
KAL-1 in certain neurons causes enhanced branching (Bulow et
al., 2002). A genetic screen for suppressors of KAL-1-induced
branching recovered mutations in genes required for secondary
modifications of HS: hst-6, encoding the C. elegans HS-6-O-
sulfotransferase, and hse-5, which encodes HS glucuronyl C-5
epimerase (Bulow et al., 2002). Loss of function of these
enzymes prevents KAL-1-induced branching, suggesting that
HSPGs are essential for KAL-1 action.
The embryonic defects of kal-1 mutants resemble those of
ephrin signaling mutants, which affect epidermal morphogen-
esis by regulating development of the substrate neuroblasts. To
decipher the relationship of KAL-1 and ephrin signaling, we
have examined the role of kal-1 in embryonic morphogenesis.
We find that kal-1 mutants display delayed migration of the
ventral neuroblasts (VNBs) that generate the substrate for
epidermal epiboly. Our analysis suggests KAL-1 does not
modulate Eph or FGF signaling. We show that specific HS
modifications play distinct roles in VNB migration, acting in a
KAL-1-dependent process. By biochemical and genetic assays,
we show that KAL-1 interacts with the HSPGs syndecan and
glypican in embryonic neuroblast migrations.
Materials and methods
Genetics and phenotypic quantitation
The wild-type strain used is Bristol N2 (Brenner, 1974). All strains were
maintained at 20°C on NGM agar under standard conditions. The following
previously described mutations were used: LG I: kal-1(gb503), mab-20(ev574);
LG II: vab-1(e2027), ptp-3(mu256); LG III: hse-5(tm472); LG IV: efn-1(e96);
LG X: sdn-1(ok449) (Minniti et al., 2004), sdn-1(zh20) (Rhiner et al., 2005), hst-
2(ok595), hst-6(ok273), sax-3(ky123), egl-15(n1456) and lin-15(n765ts).
Double and triple mutants were constructed using standard genetic methods.
Deletion alleles were genotyped by three primer multiplex PCR (with one
primer located in the deletion) to identify mutant and wild type alleles in a single
reaction. Primer sequences are available on request.
The following transgenes were used: otIs33[Pkal-1-GFP], otIs81[Punc119-
KAL-1], otEx1254[egl-15(5B)+ceh-22∷GFP] (Bulow et al., 2004), oxIs12.
In addition to gb503, a second kal-1 allele, ok1056, was isolated by the C.
elegans Gene Knockout Consortium. We determined the breakpoints of kal-1
(ok1056) and found it to be a 1033 bp deletion with a 33 bp insertion, withgenomic breakpoints 5′ AGTTTTCGATGATTTTGCGG/ATGAGAATT-
TGGCGCCAGGA 3′. ok1056 deletes most of exon 5, affecting the second
and third FNIII repeats.
Quantitation of lethal and morphological phenotypes was performed as
described (George et al., 1998). All analyses of penetrance are based on counts
of multiple (3–6) complete broods from animals raised at 20°C from outcrossed
strains; n > 500 animals for each genotype. Timelapse analysis of embryogenesis
was performed as described (Chin-Sang et al., 2002) at 20°C; n = 10–30 per
genotype for all quantitative analysis of embryogenesis. kal-1(gb503) was
previously reported to cause ∼26% embryonic lethality in a him-8(e1489)
background, compared with 13% embryonic lethality for him-8(e1489) alone.
After outcrossing we found that neither gb503 or ok1056 caused significant
embryonic lethality (Table 1).
Characterization of C. elegans glypican GPN-1
The C. elegans gene F59D12.4 encodes a member of the glypican
family. We confirmed the gpn-1 gene structure by sequencing the cDNA
yk747a2. The predicted GPN-1 protein is 543 amino acid residues, with a
molecular weight of 58.5 kDa after removal of signal sequences for
secretion and GPI anchorage. GPN-1-specific bands in SDS-PAGE gels are
smaller (30–35 kDa, Fig. 3C). HSPGs are known to run anomalously in
SDS-PAGE; additionally, glypicans are often processed by proprotein
convertases (De Cat et al., 2003), and GPN-1 contains several potential
cleavage sites.
Three alleles of gpn-1 have been isolated by reverse genetics. ok377,
generated by the Gene Knockout Consortium, is a 1195-bp deletion of part of
exon 3. tm595 (S. Mitani) deletes part of exon 2 and all of exon 3, and tm588
deletes exon 4. All three mutations cause no overt defects in epidermal
morphogenesis apart from variation in embryo size (not shown). To assay
complementation of the gpn-1(ok377) phenotype we rescued the synthetic
lethality of efn-4 ok377 double mutants. We generated transgenic arrays by
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and pBluescript (20 ng/μl) into efn-4(bx80); gpn-1(ok377) double mutants.
Multiple lines were generated, and scored for rescue of embryonic lethality: efn-
4(bx80); gpn-1(ok377); juEx955 strains displayed 7.2 ± 1.9% embryonic
lethality compared with 26.4 ± 5.3% for efn-4(bx80); gpn-1(ok377). These data
establish that the enhancement of efn-4 embryonic lethality results from the
ok377 mutation.
Analysis of HSPG expression
The functional SDN-1∷GFP reporter (jtEx36) consists of full length SDN-1
tagged at the C-terminus with GFP. Arrays containing SDN-1∷GFP rescue sdn-
1(ok449) phenotypes and will be described in detail elsewhere (T.K., in
preparation). To generate glypican reporters, 4.3 kb of the gpn-1 promoter
region was amplified and cloned into the pCR8/GW/TOPO entry vector
(Invitrogen). The insert was recombined into the pCZGY32 destination vector (a
gift from G. Gallegos) which contains Venus YFP open reading frame and the
unc-54 3′untranslated region, to yield plasmid pCZGY50. Transgenic arrays
were generated by co-injecting pCZGY50 at 10 ng/μl, and the lin-15(+) plasmid
pJM23 (Huang et al., 1994) (50 ng/μl) into lin-15(n765ts) mutants. Two
independent lines were isolated (juEx900 and juEx901) which showed similar
expression patterns. To make GPN-1∷GFP we used a modular Gateway based
destination vector (pCZGY20) containing the KAL-1 N-terminal signal
sequence (residues 1–15) followed by Venus YFP (Nagai et al., 2002). A
multiple cloning site allows insertion of promoters and the Gateway
recombination sites allow insertion of ORFs for secreted proteins. We amplified
the GPN-1 ORF and cloned it into pCR8/GW/TOPO. The GPN-1 ORF was then
recombined into a version of pCZGY20 containing the gpn-1 promoter to create
pCZGY41, which was injected at 1 ng/μl with Pttx-3-RFP (Altun-Gultekin et al.,
2001) to create the array juEx1108. Rescue of the gpn-1(ok377) phenotype was
confirmed in the efn-4(bx80) background as above. For immunostaining of GFP
transgenic animals, we used standard procedures (Finney and Ruvkun, 1990);
rabbit anti-GFP (Molecular Probes, A11122) was used at 1:1000 dilution and
MH27 supernatant at 1:100. Staining was visualized with appropriately
conjugated 2° antisera on a Zeiss Axioplan 2 or a Zeiss Pascal confocal
microscope.
HSPG biochemistry
Recombinant KAL-1∷Fc was prepared by transient transfection of 293T
cells with the pCXFc-KAL plasmid (Bulow et al., 2002). Protein was harvested
48 h post-transfection, centrifuged to remove cellular debris and 0.5 volumes of
3× binding buffer added (final concentrations: 50 mM HEPES pH 7.4, 500 mM
NaCl, 0.1% Tween-20, 1 mM PMSF, 1× Complete EDTA-free protease inhibitor
cocktail, Roche Diagnostics). KAL-1∷Fc was bound to protein-A agarose
(Roche Diagnostics) overnight at 4°C, washed once with 1× binding buffer and
once with high salt binding buffer (composition as above but with 1 MNaCl). To
minimize proteolysis, the affinity matrix was freshly prepared for each
experiment.
Embryos were isolated by alkaline lysis from gravid adults grown in 50 ml
liquid culture in 25 × 25 cm trays. Embryonic tissue was prepared by sonication
in 50 mM Tris–HCl, pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 1 mM EDTA,
1 mM PMSF, 1× Complete EDTA-free protease inhibitor cocktail, Roche
Diagnostics and allowed to solubilize for 5 h at 4°C. Samples were centrifuged
at 10 000×g for 20 min and the supernatants bound to protein-A agarose-KAL-
1∷Fc affinity matrix overnight at 4°C. Samples were washed with lysis buffer
containing 0.25 M NaCl and eluted using 1.5 M NaCl in lysis buffer, and the
eluate desalted in water on a NAP-5 sephadex column (Amersham). Samples
were concentrated using a SpeedVac, resuspended in 1× heparitinase buffer
(100 mM sodium acetate pH 7.0, 0.1 mM calcium acetate) and digested
overnight at 37°C with 2.5 mU heparitinase I (Seikagaku, Tokyo, Japan).
Samples were separated on 12% SDS-PAGE gels, blotted to PVDF membrane
and allowed to dry overnight at room temperature. After blocking in 2% non-fat
milk in TBSTw, samples were probed with 1:1000 3G10 (mouse anti-HS-stub
antibody, Seikagaku) for 2 h followed by 1:2500 HRP conjugated sheep anti-
mouse (Amersham) for 30 min. Western blots were visualized using the ECL
system (Amersham).Results
KAL-1 is required for normal migrations of ventral neuroblasts
independent of FGF signaling
Loss of function in the C. elegans anosmin-1 ortholog kal-1
has been previously reported to result in low penetrance defects
in embryonic epidermal morphogenesis that resemble those of
Eph signaling mutants (Rugarli et al., 2002). The primary
developmental defects in Eph signaling mutants are in
migrations of ventral neuroblasts (VNBs) following gastrula-
tion and prior to epidermal enclosure (Chin-Sang et al., 1999;
George et al., 1998). During gastrulation, endodermal and
mesodermal cells migrate to the center of the developing
embryo, leaving a cleft on the ventral surface flanked by VNBs
(Fig. 1) (Nance and Priess, 2004). This gastrulation cleft is
closed by short-range migrations of VNBs (Chisholm and
Hardin, 2005) that require several partly redundant cell
signaling pathways (Chin-Sang et al., 1999, 2002; George et
al., 1998; Harrington et al., 2002), as well as pathways related to
actin remodeling (Withee et al., 2004). If VNBs are misposi-
tioned at the end of enclosure, as in the above mutants,
epidermal cells fail to make correct contacts with their
contralateral partners, leaving a hole in the ventral surface of
the epidermis and leakage of internal cells. However, short
delays in VNB migrations are often compatible with epidermal
enclosure.
We examined embryos mutant for the putative genetic null
mutation kal-1(gb503) using 4D time-lapse microscopy and
found that although early gastrulation movements and the onset
of VNB migrations were normal, closure of the gastrulation
cleft was delayed compared to wild type (Figs. 1A, C, D).
Despite this delay, the gastrulation cleft closed before epidermal
enclosure in kal-1mutants and all animals underwent epidermal
enclosure and elongation. A second deletion allele, kal-1
(ok1056) causes VNB migration defects indistinguishable from
those of kal-1(gb503) (Fig. 1D); all analyses below use kal-1
(gb503). The similarity of phenotype of two independent
deletion alleles suggests that these phenotypes are caused by
elimination of KAL-1 function and that KAL-1 promotes VNB
cell migrations.
The kal-1 promoter is active in many cells in the embryo
(Bulow et al., 2002; Rugarli et al., 2002); using timelapse
analysis, we found that kal-1 is expressed in most VNBs from
mid gastrulation stages onwards (Fig. 1B). KAL-1 is
predicted to be GPI-anchored to the cell membrane and is
restricted to the surfaces of cells that express it (Bulow et al.,
2002). Thus, KAL-1 likely acts locally on the surfaces of
VNBs to promote their migrations. Overexpression of KAL-1
from a pan-neural promoter causes epidermal morphogenetic
defects (Bulow et al., 2002). We found that these likely result
from VNB migration defects (Fig. 1D). The defects caused by
pan-neural KAL-1 were further enhanced in a kal-1(gb503)
background (not shown), indicating that overexpression or
misexpression of KAL-1 interferes both with normal KAL-1
signaling and additional pathways involved in VNB migra-
tion. These results are consistent with KAL-1 functioning cell
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movements.
As anosmin-1 has been linked to FGF signaling in
humans, we tested whether loss of FGF signaling affects
VNB migrations. In C. elegans, a single locus, egl-15,
encodes two FGF receptor isoforms, EGL-15A and EGL-
15B (Goodman et al., 2003). Null mutations in egl-15 confer
early larval lethality reflecting the essential function of LET-
756/EGL-15B signaling (Huang and Stern, 2004). VNB
migrations in egl-15 null mutant embryos derived from
heterozygous mothers were normal (Fig. 1D). To address the
possibility of maternal rescue of egl-15 function, we also
analyzed VNB migrations in egl-15 mutant embryos derived
from mothers that had lost egl-15 function in the germline,
and observed normal VNB migrations. We conclude that
FGF signaling does not influence VNB migration, and
therefore that KAL-1 is unlikely to act through FGFR in this
context.
We then tested whether kal-1 interacted with four
pathways known to function in both embryonic VNB
migrations and in axon guidance: the VAB-1/Eph receptor-
EFN-1/ephrin pathway (Chin-Sang et al., 1999; George et al.,
1998), the PTP-3 (LAR-like RPTP) pathway (Harrington et
al., 2002), the ephrin EFN-4, which may act in MAB-20/
Semaphorin 2A signaling (Chin-Sang et al., 2002; Ikegami et
al., 2004), and SAX-3/Robo signaling (Ghenea et al., 2005).
In all double mutants tested, kal-1(gb503) significantly
enhanced VNB migration defects, epidermal enclosure
defects, and embryonic lethality relative to the single mutants
(Fig. 1E; Supplemental Fig. 1; Table 1). As kal-1 enhances
null mutations in these genes, KAL-1 is unlikely to act solely
as a component of the Eph, LAR, EFN-4/semaphorin 2A, or
Robo pathways. KAL-1 instead acts in parallel to promote a
common process in VNB migration.
Heparan sulfate synthesis and specific HS modifications are
important for neuroblast migrations
Both mammalian anosmin-1 and C. elegans KAL-1 have
been linked to heparan sulfate proteoglycans (HSPGs) (Bulow
et al., 2002; Soussi-Yanicostas et al., 1996, 1998). To test if
HSPGs were required for embryonic VNB migrations we first
examined mutants defective in HS synthesis or modification.
C. elegans enzymes catalyzing all known steps in HS
synthesis and modification have been identified (Bulow and
Hobert, 2004), and deletion alleles of the genes are available
(Fig. 2A). Promoters for hst-2, hse-5, and hst-6 are active in
multiple tissues during embryogenesis (Bulow and Hobert,
2004).
Embryos lacking the enzymes required for HS polymer-
ization (RIB-1, RIB-2) (Morio et al., 2003) or for deacetyla-
tion and N-sulfation of glucosamine (HST-1) display defects
in VNB movements much more severe than those of kal-1
mutants (M.L.H. and A.D.C., unpublished results), showing
that HSPGs are essential for VNB migrations. In contrast,
mutants lacking the glucuronic acid C5 epimerase HSE-5 or
the sulfotransferases HST-2 and HST-6 are mostly viable anddisplay low-penetrance defects in epidermal morphogenesis
(Table 2); we refer to this group of genes as HS modification
genes. In timelapse analysis of VNB migrations, lack of HSE-
5 C5 epimerase caused the most dramatic defects within this
group, with a mean gastrulation cleft duration of 96 ± 7 min
(Figs. 2C, D) and 6 ± 2% embryonic lethality (Table 2). kal-1
hse-5 double mutants were not significantly different from
hse-5 single mutants either in overall lethality or in VNB
migration, suggesting that KAL-1 function in morphogenesis
involves C5-epimerized HSPGs. hst-6 mutants displayed
milder VNB migration defects (mean cleft duration
86 ± 7 min). hst-6 kal-1 double mutants resemble hst-6
single mutants, implying that the HSPGs involved in KAL-1
function are also 6-O-sulfated. In these mutants, onset of cleft
opening was normal relative to E daughter ingression, but
closure was delayed (Fig. 2B). A mutation in hst-2 did not
significantly affect VNB migrations, yet hst-2 kal-1 double
mutants were enhanced relative to kal-1, suggesting 2-O-
sulfated HSPGs have cryptic roles in VNB migration.
Because kal-1 and HS modification mutations confer
relatively mild effects as single mutants, lack of enhance-
ment in a double mutant might reflect additivity, and thus
does not necessarily imply a common pathway. As a more
sensitive test of whether kal-1 and HS modification
mutations affect a common pathway, we constructed triple
mutants of genotype efn-4 kal-1 mut. Because kal-1 strongly
enhances efn-4 phenotypes, mutations affecting the kal-1
pathway should also enhance efn-4 but should not further
enhance an efn-4 kal-1 double mutant. We found that HS
modification mutations dramatically enhanced efn-4 pheno-
types (Table 1). hst-6 enhanced efn-4 embryonic phenotypes
to the same extent as kal-1, and a kal-1 efn-4 hst-6 triple
mutant resembled kal-1 efn-4 in overall lethality (Table 2)
and VNB migration, consistent with 6-O-sulfated HSPGs
acting in a KAL-1 pathway to promote VNB migration. hse-
5 efn-4 double mutants displayed enhanced morphogenetic
phenotypes relative to kal-1 efn-4 and were indistinguishable
from kal-1 hse-5 efn-4 triple mutants (Table 2). These data
are consistent with KAL-1 functioning via C5-epimerized
HSPGs, and also suggest that HSE-5 has other HSPG targets
in addition to those involved in KAL-1 signaling. Finally,
hst-2 efn-4 double mutants show significantly higher
embryonic lethality relative to efn-4 alone, and a kal-1 efn-
4 hst-2 triple mutant is further enhanced, consistent with
KAL-1 and 2-O-sulfated HSPGs acting in parallel pathways
(Table 2).
In summary, the different HS modifications have different
roles in VNB migration and in the KAL-1 pathway. HSPGs
modified by either HSE-5 and/or HST-6 promote VNB
migrations; loss of HSE-5 function has the strongest effects,
paralleling its requirement in axon guidance (Bulow and
Hobert, 2004). Our double mutant analysis argues that KAL-1
interacts with 6-O-sulfated HSPGs; HSPGs modified by C-5-
epimerase likely have additional roles. Lack of HST-2 has no
obvious effect, but synergizes with kal-1 mutations and with
efn-4 mutations, suggesting a cryptic role for 2-O-sulfated
HSPGs.
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an HS dependent interaction
Our studies suggested that KAL-1 acts with one or more
HSPGs in VNB migration. C. elegans encodes at least four
potential HSPG core proteins: the cell surface HSPGs syndecan/SDN-1 (Minniti et al., 2004; Rhiner et al., 2005) and glypican/
GPN-1 (Fig. 3A; Materials and methods), and the basement
membrane HSPGs perlecan (Rogalski et al., 1993) and collagen
XVIII/CLE-1 (Ackley et al., 2001). Of these only SDN-1 has
been shown to be decorated by heparan sulfate chains (Minniti
et al., 2004). To determine which HSPGs interacted with KAL-1
357M.L. Hudson et al. / Developmental Biology 294 (2006) 352–365we first used affinity chromatography. We expressed KAL-
1∷Fc in HEK293 cells and showed that it is N-glycosylated and
binds heparin in vitro (Fig. 3B). We coupled KAL-1∷Fc to a
solid matrix and passed extracts of C. elegans embryos over the
columns. To detect KAL-1-binding HSPGs we digested eluates
from the KAL-1 affinity column with heparitinase and probed
blots with an antibody that recognizes HS ‘stubs’ generated by
heparitinase digestion (Fig. 3C, WT lane). We consistently
detected HSPGs of apparent molecular weight 50–56 kDa and
∼35 kDa. Based on their elimination in extracts from mutants,
these bands correspond to two isoforms of SDN-1 and a
possible cleavage product of GPN-1 (Fig. 3 legend). Both SDN-
1 and GPN-1 were eluted from KAL-1∷Fc columns by heparin,
indicating that the binding is HS-dependent. Neither SDN-1 nor
GPN-1 were enriched by control columns of Fc bound to
protein A. Equal volumes of wild type extracts were analyzed as
a loading control and were not enriched for SDN-1 or GPN-1
(Fig. 3C). As our genetic analysis suggested that C5
epimerization and 6-O-sulfation affected the KAL-1 pathway,
we tested whether these modifications were required for the
KAL-1/HSPG interaction. We found that HSPGs from hse-5 or
hst-6mutant extracts were not enriched by KAL-1∷Fc columns
(Fig. 3C). We conclude that KAL-1 binds SDN-1 and GPN-1
via their HS side chains and that this binding requires the C5
epimerization and 6-O-sulfation of HS.
Syndecan SDN-1 and Glypican GPN-1 are expressed in ventral
neuroblasts and have redundant roles in VNB migration
Our biochemical analyses indicated that KAL-1 interacts
with at least two HSPGs, syndecan and glypican. We asked
whether SDN-1 or GPN-1 were expressed during VNB
migrations using transcriptional reporters (gpn-1, Fig. 4G;
sdn-1-GFP not shown) and functional GFP-tagged constructs
(see Materials and methods). SDN-1∷GFP transgenes were
expressed in many ventral neuroblasts during their migrations,
prior to and during epidermal enclosure (Figs. 4A–C); in later
embryogenesis (Figs. 4D–F) SDN-1∷GFP was mainly
expressed in the nervous system (nerve ring localization, nr)
and pharynx (ph). GPN-1∷GFP was expressed in a smaller
number of neuroblasts prior to epidermal enclosure (Figs. 4H,
I). In later embryogenesis GPN-1∷GFP was expressed strongly
in the developing pharynx (Figs. 4J–L) and in ventral cordFig. 1. KAL-1 functions in ventral neuroblast movements. (A) Timelapse analyses of
at ∼100 min post first cell division, when the Ea and Ep cells ingress to the center o
division, a transient depression, the gastrulation cleft, opens on the ventral surface o
mesodermal precursors enter the interior. In kal-1mutants, the cleft is visible for ∼80
are ventral before enclosure and thereafter lateral; scale, 10 μm. (B) Expression of
ventral midline (dashed line, 360 min). DIC (right panels) and GFP fluorescence (left)
1 mutants. Early gastrulation events (Ea/p ingression to cleft opening) are normal in k
nevertheless undergo epidermal enclosure and reach comma stage slightly earlier than
duration in wild type, kal-1 loss and gain of function, and egl-15 null mutants. Cleft du
otIs81 gain of function embryos compared to the wild type (P < 0.0001). egl-15(n1
from n1456 homozygotes balanced by the egl-15(+) array otEx1254. Germline clon
GFP marker. VNB migration was not significantly different from the wild type in ei
migration in null or strong loss of function mutations of the following genes: Eph re
(bx80); LAR-related receptor tyrosine phosphatase, ptp-3(op147); Robo, mab-20(
significant delays in VNB migration compared to the single mutant (P < 0.01 for eaneurons (Fig. 4L, arrows). As both cell surface HSPGs are
expressed in ventral neuroblasts, KAL-1 could potentially
interact with both, either on the same cells or on adjacent cells
during VNB migrations.
We then tested whether HSPGs function in VNB migrations
and whether they act in the KAL-1 pathway. gpn-1(ok377)
mutants had delayed VNB migrations with a mean gastrulation
cleft duration of 64 ± 3 min (Fig. 5). kal-1 gpn-1 double mutants
did not synergize (3.4% embryonic lethality; Table 2) whereas
efn-4 gpn-1 double mutants were synergistically enhanced
(25.5% embryonic lethality) suggesting GPN-1, like KAL-1,
acts in parallel to EFN-4 in embryogenesis. kal-1 efn-4 gpn-1
triple mutants resembled kal-1 efn-4 double mutants (41.9% and
35.9% embryonic lethality respectively). Thus, kal-1 and gpn-1
both enhance efn-4, but the triple mutant is not further enhanced
relative to the most penetrant double mutant, consistent with
kal-1 and gpn-1 affecting a common pathway. VNB migrations
of kal-1 gpn-1 double mutants were delayed compared to kal-1
or gpn-1 single mutants, suggesting GPN-1 also has KAL-1-
independent functions in VNB migration (Fig. 5).
sdn-1 mutants display low penetrance morphogenetic
defects (Table 2; Fig. 5). We compared the phenotypes
caused by the sdn-1 null mutation zh20 (Rhiner et al., 2004)
and the in-frame deletion allele ok449. ok449 removes two of
three predicted HS attachment sites (Minniti et al., 2004), and
may eliminate HS-modified SDN-1. sdn-1(zh20) mutants
displayed variably delayed VNB migrations, although this
was not statistically significant; sdn-1(ok449) embryos had
normal VNB migrations. Thus, SDN-1 is not individually
required for VNB migrations. Both alleles of sdn-1 strongly
synergized with efn-4 (Table 2); this synergism is stronger
than that seen for efn-4 kal-1 and implies that SDN-1 does not
only interact with KAL-1. Indeed, kal-1 efn-4 sdn-1 triple
mutants were completely inviable. Both zh20 and ok449
caused slight enhancement of embryonic lethality in kal-1
genetic backgrounds (7.9% and 8.3% respectively). However,
VNB migrations of kal-1 sdn-1(ok449) were not significantly
different from those of kal-1 suggesting that the HS-
dependent functions of SDN-1 in VNB migration affect the
KAL-1 pathway. kal-1 sdn-1(zh20) double mutants displayed
delayed VNB migrations relative to kal-1. Thus, SDN-1
appears to have at least two roles in VNB migration: an HS-
dependent role, specifically affected in ok449, that may affectwild type (N2) and kal-1(gb503) embryos. In C. elegans gastrulation commences
f the embryo (arrowheads, 100 min time point). At about 200 min post first cell
f the embryo. The cleft is visible for ∼55 min (dashed lines) in wt embryos, as
min (see 260 min). In this and all subsequent figures, anterior is to the left; views
kal-1 promoter transgene (otIs33) in VNBs during their migration towards the
channels from timelapse movie. (C) Developmental timing in wild type and kal-
al-1 mutants (black bars). Closure of the cleft is delayed in kal-1 mutants, which
the wild type (white bars, P < 0.05 for N2 v ok1056; t test). (D) Gastrulation cleft
ration is significantly longer in gb503 and ok1056 loss of function mutants and in
456) mutant embryos were derived from heterozygous n1456/oxIs12 parents or
es were identified as animals whose broods completely lacked expression of the
ther situation. Number of embryos analyzed is shown within each bar. (E) VNB
ceptor, vab-1(e2027); canonical ephrin, efn-1(e96); non-canonical ephrin, efn-4
ev574). In all cases, double mutants with kal-1(gb503) (red bars) displayed
ch pairwise comparison).
Fig. 2. Heparan sulfate modifications are required in VNB migrations. (A) Outline of HS synthesis in C. elegans. The first specific step in synthesis of HS GAG side
chains is the addition of GlcNAc (blue) to the tetrasaccharide core. This commits the side chain to HS (rather than CS) synthesis and allows polymerization of the HS
by Exostosin family copolymerases, represented in C. elegans by RIB-1 and RIB-2 (Morio et al., 2003). HST-1 is orthologous to GlcNAc N-deacetylase-N-
sulfotransferase (NDST), which acts on regions of the nascent HS chain by de-acetylating N-acetyl glucosamine residues and replacing the acetyl group with a sulfate
(yellow). HSE-5 is the C. elegans ortholog of glucuronyl C-5 epimerase, which epimerizes some GluA residues within the N-sulfated glucosamine regions to IdoA
(green), providing flexibility to the HS chain. Finally, sulfotransferases HST-2/UroA-2-O-sulfotransferase, HST-3/GlcNS-3-O-sulfotransferase and HST-6/GlcNS-6-
O-sulfotransferase provide additional sulfation of IdoA/GlcA and GlcNS residues. (B) Frames from 4D movies of hst-6(ok273) and kal-1 hst-6 double mutants
showing gastrulation cleft (red outline). (C) Gastrulation cleft duration in HS modification mutants and kal-1 double mutants (red bars). Only hst-6 and hse-5mutations
cause longer cleft duration compared to wild type (P < 0.005 for each). These defects are not enhanced in double mutants with kal-1. (D) All HS modification mutants
develop more rapidly from onset of gastrulation to comma stage. The reason for this accelerated development is not yet known, but suggests that HSPGs also affect
later aspects of epidermal morphogenesis.
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the null mutant) that are independent of KAL-1.
Our analysis shows that SDN-1 and GPN-1 have cryptic
functions in embryonic morphogenesis and VNB migrations.
To ask whether SDN-1 and GPN-1 themselves act redundantly
we examined sdn-1 gpn-1 double mutants and found that theydisplayed delayed VNB migrations (Fig. 5) comparable to those
of kal-1mutants (cleft duration of 81 ± 8 min). We conclude that
SDN-1 and GPN-1 have partly redundant roles in VNB
migration. To test the in vivo relationships between KAL-1
and the HSPG core proteins, we examined kal-1 sdn-1 gpn-1
triple mutants. These triple mutants were not further enhanced
Table 2
Genetic interactions of kal-1 with heparan sulfate modification enzyme and
HSPG core protein mutations
Genotype Embryonic lethality
(%) ±SEM
Larval lethality
(%) ±SEM
Adult Vab
morphology
(%) ±SEM
(A) HS modification enzymes
Wild type 0.1 ± 0.1 0.1 ± 0.1 0.1 ± 0.2
kal-1(gb503) 0.6 ± 0.6 ns 0.2 ± 0.2 ns 5.6 ± 0.7***
efn-4(bx80) 11.5 ± 1.1 9.0 ± 1.8 31.2 ± 1.7
kal-1 efn-4 35.3 ± 4.2*** 24.1 ± 2.5*** 26.2 ± 1.4*
hst-2(ok595) 2.9 ± 1.6 0.4 ± 0.2 0.8 ± 0.2
kal-1 hst-2 1.5 ± 0.9 ns 3.2 ± 2.9 ns 2.0 ± 0.4 ns
efn-4 hst-2 52.9 ± 3.2 22.8 ± 1.5 20.1 ± 1.5
kal-1 efn-4
hst-2
81.0 ± 6.1*** 12.6 ± 1.7*** 2.5 ± 1.0***
hse-5(tm472) 5.9 ± 2.3 1.0 ± 0.4 12.6 ± 0.7
kal-1 hse-5 5.9 ± 1.7 ns 0.9 ± 0.3 ns 11.7 ± 1.2 ns
efn-4 hse-5 87.5 ± 5.9 10.1 ± 4.6 1.2 ± 0.9
kal-1 efn-4
hse-5
89.0 ± 3.8 ns 6.4 ± 0.7 ns 1.0 ± 0.3 ns
hst-6(ok273) 1.3 ± 0.6 0.0 ± 0.0 0.6 ± 0.3
kal-1 hst-6 1.7 ± 0.3 ns 0.0 ± 0.0 ns 2.6 ± 0.8 ns
efn-4 hst-6 58.5 ± 6.5 22.0 ± 1.7 13.0 ± 2.8
kal-1 efn-4
hst-6
66.2 ± 4.4 ns 22.2 ± 3.3 ns 10.3 ± 2.0 ns
(B) HS core protein mutations
gpn-1(ok377) 3.5 ± 1.3 0.0 ± 0.0 0.8 ± 0.6
kal-1 gpn-1 3.4 ± 1.4 ns 0.4 ± 0.3 ns 3.3 ± 1.1 ns
efn-4(bx80) 11.5 ± 1.1 9.0 ± 1.8 31.2 ± 1.7
efn-4 gpn-1a 25.5 ± 5.5* 6.8 ± 1.1 ns 34.4 ± 3.9 ns
kal-1 efn-4
gpn-1
41.9 ± 6.8* 24.4 ± 2.1*** 19.7 ± 4.0
sdn-1(ok449) 1.5 ± 0.7 0.3 ± 0.0 4.2 ± 1.0
kal-1 sdn-1
(ok449)
8.3 ± 1.7*** 6.5 ± 2.0* 8.8 ± 1.0*
efn-4 sdn-1
(ok449)a
54.6 ± 6.2** 29.3 ± 3.2** 13.6 ± 2.0*
sdn-1(zh20) 2.5 ± 1.3 1.3 ± 0.7 4.8 ± 1.0
kal-1 sdn-1
(zh20)
7.9 ± 2.2 ns 3.0 ± 1.0 ns 10.3 ± 1.8*
efn-4 sdn-1
(zh20)a
62.8 ± 2.8*** 27.9 ± 2.0*** 6.8 ± 1.0***
gpn-1 sdn-1
(zh20)
2.8 ± 1.1 1.3 ± 0.2 5.0 ± 1.0
kal-1 gpn-1
sdn-1(zh20)
5.9 ± 1.2* 6.8 ± 1.3** 5.6 ± 1.1 ns
Embryonic lethality, larval lethality and adult epidermal morphology were
scored in heparan sulfate modification and core protein mutants and in double
and triple mutants with kal-1(gb503) or efn-4(bx80). (A) kal-1 and efn-4
interactions with null mutations in HS modification enzyme genes. (B) kal-1 and
efn-4 interactions with HSPG core protein mutations. n > 500 F1 animals (3–6
complete broods) for all genotypes. Significance values (t test, see Table 1) are
between the matched kal-1(+) and kal-1(−) strains or between matched efn-4(+)
and efn-4(−) strains (a).
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together, these genetic data are consistent with our biochemical
results that KAL-1 interacts with both SDN-1 and GPN-1.
Discussion
Our goal was to identify the specific partners of KAL-1/
Anosmin-1 in neuronal cell migrations. We find that the C.elegans anosmin-1 ortholog KAL-1 promotes the migrations
of neuroblasts during embryogenesis. KAL-1 is broadly
expressed in the ventral neuroblasts from mid gastrulation
stages onwards. Although anosmin-1 has been implicated in
FGF signaling, we find that FGF signaling does not act in
VNB migrations, suggesting that KAL-1 does not modulate
FGF signaling in C. elegans. Using double mutant analysis
we show that KAL-1 action in neuroblast migration involves
C5-epimerized and 6-O-sulfated HS chains attached to the
cell surface HSPGs syndecan and glypican. These genetic
results are consistent with our biochemical evidence for an
HS-dependent interaction of KAL-1 with SDN-1 and GPN-
1. This is the first demonstration of interactions of KAL-1/
Anosmin-1 proteins with specific HSPGs and will allow the
KAL-1/HSPG interaction to be manipulated by overexpres-
sion or misexpression of these core proteins.
The essential role of HSPGs in early development
Heparan sulfate proteoglycans have been implicated in
numerous developmental processes and signaling pathways
(Kramer and Yost, 2003; Lin, 2004). Insights into HSPG
function have come from analysis of mutations affecting core
proteins and of mutations in enzymes that catalyze synthesis
and modification of HS side chains. The C. elegans complement
of HSPGs is small relative to vertebrates, with known HSPG
families represented by a single gene. C. elegans contains a
single syndecan and at most two glypicans; a second C. elegans
glypican-like protein, LON-2, does not appear to function in
VNB migration (data not shown). The basement membrane
HSPGs perlecan and type XVIII collagen have been character-
ized in detail, and do not appear to function in VNB migrations
(not shown). The functions of C. elegans orthologs of two other
HSPGs, the membrane protein agrin and the secreted protein
testican, have not been reported.
In C. elegans, abrogation of HS synthesis confers dramatic
defects in embryonic cell migrations. It is not yet understood
why HS is essential for C. elegans embryogenesis, but this
finding parallels results in other animals. In mice, deletion of the
major HS glycosyltransferase Ext1 causes lethality at gastrula-
tion and failure to form mesoderm, reflecting roles for HS in
multiple signaling pathways (Lin et al., 2000). In Drosophila,
lack of HS disrupts signaling in at least three pathways,
Hedgehog, Wingless, and Dpp (Bornemann et al., 2004). In C.
elegans only Wg signaling is known to be essential for
embryogenesis, as it is required for induction of the gut.
However gut induction and early embryogenesis appear normal
in rib and hst-1 mutants, suggesting that HS has essential
functions in other pathways.
The functions of HSPGs in neural development have been
explored in a variety of species. Tissue-specific deletion of Ext1
in the mouse CNS causes dramatic defects in neural
development, attributed to reduced FGF and Slit signaling
(Inatani et al., 2003). The tissue-autonomy of these defects
further suggests that cell surface HSPGs are involved in CNS
development. Reduced HS synthesis disrupts axon sorting in
the zebrafish optic tract (Lee et al., 2004). The signaling
Fig. 3. KAL-1 binds GPN-1 and SDN-1 via an HS-dependent interaction. (A) The genomic structure of gpn-1 and location of deletion alleles is shown. GPN-1 contains
three predicted HS attachment sites (HS) and four potential cleavage sites for proprotein convertase (triangles) (B) KAL-1∷Fc expressed in 293Tcells binds to heparin
sepharose; removal of glycan moieties by N-glycosidase F (PNGase) reduced the molecular weight but did not abolish the HS interaction. (C) Extracts from C. elegans
embryos were bound to KAL-1∷Fc columns, eluted with 1.5 M NaCl, and desalted on NAP5 sepharose columns. Eluted fractions were digested with heparatinase I to
remove HS side chains, separated by SDS-PAGE, blotted and probed using the anti-HS stub monoclonal 3G10. Western blot of elutions of extracts from N2 (wild type)
and gpn-1(ok377) mutant embryos. Approximately equal amounts of extract were applied. Two prominent bands are seen in the N2 lane at ∼50 and ∼30 kDa; the
50 kDa band corresponds to SDN-1 (Minniti et al., 2004); we identify the 30 kDa band as a GPN-1 product as it is absent from gpn-1(ok377)mutants. Aweaker band at
∼55 kDa appears to be an isoform of SDN-1. In extracts from wild type (N2; a longer exposure than in the right panel) and sdn-1(zh20) single mutants, and sdn-1(zh20)
gpn-1(ok377) double mutant embryos, three major bands (solid arrows) are seen in the N2 lane, the 50 and 55 kDa bands are absent from the sdn-1 lane, and all three
bands are missing from the double mutant lane. Aweak∼80 kDa band seen at approximately equal intensity in all samples (arrowhead) may correspond to the 80 kDa
HSPG observed by Minniti et al. (2004). SDN-1 and GPN-1 from wild type extracts bound to KAL-1 columns were specifically eluted with 100 μg/ml heparin,
showing that the KAL-1-HSPG interaction is HS-dependent. SDN-1 and GPN-1 were absent from eluates from an Fc control column. In extracts corresponding to the
N2 input we see no enrichment for SDN-1 or GPN-1; a higher molecular weight HSPG is seen (large arrowhead) that does not correspond to any species enriched over
KAL-1 columns, suggesting that KAL-1 interacts with specific HSPGs. Extracts were prepared from the wild type and from hse-5 and hst-6 mutants, bound to KAl-
1∷Fc and eluted at low and high salt. Only wild type extracts contained KAL-1-interacting HSPGs.
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Fig. 4. SDN-1 and GPN-1 are expressed in the developing nervous system and pharynx. (A–F) Expression of functional SDN-1∷GFP (jtEx36) in embryos during
VNB migrations and epidermal enclosure. (A) DIC and GFP fluorescence of SDN-1∷GFP in ventral neuroblasts prior to epidermal enclosure (300 min). (B–F) SDN-
1∷GFP (anti-GFP immunostaining, green) and epidermal adherens junctions (MH27, red) in embryos. (B), SDN-1∷GFP is expressed in many ventral neuroblasts
prior to epidermal sheet movement; ventral view. (C) SDN-1∷GFP in ventral neurons at late enclosure. (D–F) SDN-1∷GFP in neurons and pharynx (ph); SDN-
1∷GFP localization to the nerve ring (nr) is prominent. Panels C–F and I–L are projections of confocal Z-stacks. (G) Pgpn-1∷GFP (juEx900) is expressed in the
developing pharynx and a small number of ventral neuroblasts (arrow) at bean stage (360 min). Expression is also occasionally seen in the gut and in 3–4 dorsal
epidermal cells prior to enclosure. (H–L) Anti-GFP and MH27 immunostaining of functional GPN-1∷GFP (juEx1108) in embryos. GPN-1∷GFP is expressed in
several ventral neuroblasts prior to epidermal sheet movement (H); in later stages GPN-1∷GFP is confined to the pharynx (ph) and some ventral cord motor neurons
(arrows, L). Scale, 10 μm.
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Fig. 5. SDN-1 and GPN-1 have redundant functions in neuroblast migrations. (A) 4-D panels from sdn-1 gpn-1 double mutants and kal-1 sdn-1 gpn-1 triple mutants
showing lack of enhancement. (B) Quantitation of VNB migrations of sdn-1 and gpn-1 core protein mutants, either alone or in combination with kal-1(gb503). gpn-1
and sdn-1 mutants show slightly delayed VNB migrations. sdn-1(ok449) gpn-1(ok377) and sdn-1(zh20) gpn-1(ok377) double mutants display delayed VNB
migrations that resemble those of kal-1 mutants. The kal-1 sdn-1 gpn-1 triple mutant is not significantly enhanced relative to kal-1 sdn-1(zh20) or kal-1 gpn-1 double
mutants. (C) Developmental timing of HSPG core protein mutants during morphogenesis. gpn-1(ok377) shows accelerated development from gastrulation to comma
stage similar to that of HSmodification mutants. sdn-1(zh20) displays normal developmental timing, and does not enhance the gpn-1 timing phenotype, suggesting that
VNB migration and later morphogenesis are genetically separate events.
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known; the roles of anosmin-1 in axon branching suggest that
anosmin-1 is a candidate for these functions in optic tract
development.
KAL-1, SDN-1 and GPN-1 promote movements of C.
elegans ventral neuroblasts. KAL-1 is strongly expressed in
the VNBs from early in development, and is likely to be
present on the surfaces of VNBs as they move. Based on the
overlapping expression of KAL-1, SDN-1, and GPN-1 in the
VNBs, all three molecules may interact ‘in cis’ on the same
cell surface (as shown in Fig. 6), or in trans, between adjacent
neuroblasts. Both SDN-1 and GPN-1 (but not KAL-1) are
strongly expressed in the developing pharynx. Pharyngeal
precursors are internal to some ventral neuroblasts and couldpotentially provide a substrate for VNB migrations, with
neuronally expressed KAL-1 interacting with pharyngeal
HSPGs.
The roles of specific HS modifications
Mutations affecting HS modification enzymes should affect
HS on multiple core proteins, and thus allow analysis of
redundant functions of multiple HSPG core proteins. The
effects of HS modification mutations on VNB migration are
similar to those of sdn-1 gpn-1 double mutants, suggesting that
SDN-1 and GPN-1 may be the major core proteins involved. In
general, lack of HS modifications has remarkably specific
effects on C. elegans development (Bulow and Hobert, 2004;
Fig. 6. Molecules and interactions involved in VNB migrations. Summary of interactions between KAL-1, SDN-1 and GPN-1 via HS side chains. Interactions are
shown as occurring on the same membrane (in cis) but may also occur in trans, either between adjacent neuroblasts or between neuroblasts and pharyngeal precursors
during VNB movements.
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have restricted roles, acting as specific surface codes for
signaling molecules (Habuchi et al., 2004; Holt and Dickson,
2005). Our analysis of embryonic VNBmigrations suggests that
in this process KAL-1 interacts with HSPGs that are modified
by HSE-5 and HST-6, but not by HST-2. This result is borne out
by biochemical evidence that the KAL-1/HSPG interaction
requires glucuronyl C5 epimerization and 6-O-sulfation. The
KAL-1 gain of function axon branching phenotype in the AIY
neurons likewise requires HSE-5 and HST-6, and is partly
dependent on HST-2 (Bulow and Hobert, 2004). Thus, VNB
migration and axon branching may involve KAL-1 interaction
with similarly modified HSPGs. An apparent difference
between the KAL-1 loss and gain of function phenotypes is
that a KAL-1 gain of function epidermal morphogenesis
phenotype, caused by pan-neural expression of KAL-1, is
suppressed by hse-5 but not by hst-6 (Bulow et al., 2002). If 6-
O-sulfation is required for KAL-1/HSPG interactions in VNB
migration and AIY branching, why does lack of HST-6 not
suppress the effects of pan-neural KAL-1? We hypothesize that
pan-neural expression of KAL-1 combines both overexpression
and misexpression, in contrast to overexpression in cells that
normally express KAL-1 such as AIY. Pan-neural KAL-1 may
therefore interact with HSPGs that it does not normally come
into contact with. If such HSPGs are not 6-O-sulfated, loss of
HST-6 activity may be insufficient to suppress the effects of
KAL-1 misexpression.
The role of HSPGs in KAL-1/Anosmin-1 signaling
Why does KAL-1 function require HSPGs? An attractive
model, based on the identification of FGFR1 mutations in
autosomal dominant KS, has been that anosmin-1 signals via
FGF receptors. The requirement for HSPGs in Anosmin-1
function could be thus explained by the important role for HS asa cofactor in FGF-FGFR interactions (Pellegrini, 2001). Our
results suggest that this is not sufficient to account for the roles
of KAL-1 in C. elegans VNB migrations, as we have been
unable to detect a role for the FGFR in these cell migrations.
Reduction in FGFR signaling also does not suppress the KAL-1
gain of function branching phenotype (Bulow et al., 2002).
These results suggest that KAL-1 interacts with other receptors
to regulate cell movement and branching.
Our results are more consistent with models whereby cell
surface HSPGs anchor or localize KAL-1 so that it can act on
extracellular matrix. Like anosmin-1, KAL-1 may locally
activate ECM serine proteases (Hu et al., 2004), causing local
degradation of ECM to promote ventral neuroblast migration
and axonal branching. The apparent cell autonomy or local role
of KAL-1 in branching and VNB migration imply that any
effect on ECM must be highly localized to the surface of KAL-
1-expressing cells. The migrations of ventral neuroblasts occur
concurrently with early stages of basement membrane forma-
tion in C. elegans embryos (Huang et al., 2003), although it is
not known if a basement membrane is necessary for VNB
movements. The role of the ECM in modulating axonal
branching also has yet to be tested. As the C. elegans genome
does not encode the urokinase type plasminogen activator-like
serine proteases linked to Anosmin-1 function, genetic and
biochemical approaches will be required to find the ECM
partners of KAL-1.
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